Pimera was founded by Denis Drygin.

How much funding has Pimera raised?

Pimera has disclosed $2.2M raised across 1 round.

Where is Pimera headquartered?

Pimera is headquartered in San Diego, US.

Pimera

San Diego, US · Delaware corporation

Pimera is a privately held biopharmaceutical company developing small-molecule cancer therapeutics, including RNA polymerase I inhibitors that activate nucleolar stress to treat hematologic and other cancers. It focuses on oncology drug discovery and development.

Biotech Healthtech

Founders & leadership

Denis DrygininFounder (former VP of R&D)

Brian T. DorseyChief Development Officer (CDO)

Mustapha HaddachFounder, President & CEO

Reported raises · per SEC filings

Form D private placements

$2.2M disclosed across 1 round · 2020

▶$2.2MraisedMay 2020 · 13 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Mustapha HaddachExecutive Officer, Director

Offering amount: $6.5M
Amount sold: $2.2M
First sale: Feb 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Deciphera3 shared keywordsDeciphera is a pharmaceutical company focused on developing treatments for people living with cancer. Its work centers on oncology drug development and support for patient communities.

Chimera Bioengineering3 shared keywordsChimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy. The company focuses on treating solid tumors and other currently incurable cancers through localized, controlled immune cell activation.

Companies competing with Pimera for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Pimera do?: Pimera is a privately held biopharmaceutical company developing small-molecule cancer therapeutics, including RNA polymerase I inhibitors that activate nucleolar stress to treat hematologic and other cancers. It focuses on oncology drug discovery and development.
Who founded Pimera?: Pimera was founded by Denis Drygin.
How much funding has Pimera raised?: Pimera has disclosed $2.2M raised across 1 round.
Where is Pimera headquartered?: Pimera is headquartered in San Diego, US.